Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial
hyperplasia and progressive joint destruction. Rheumatoid arthritis synovial fibroblasts …

Abstract Development of the treat‐to‐target (T2T) strategy, the process whereby drug
therapy is adjusted until the therapeutic goal is achieved, has revolutionized how …

Objective. It remains unclear whether autoantibodies are useful biomarkers to tailor the
choice of biological treatment in RA. We investigated the relationship between the presence …

The tocotrienol-rich fraction (TRF) from palm oil contains vitamin E, which possesses potent
antioxidant and anti-inflammatory activities. Rheumatoid arthritis (RA) is a chronic joint …

level longitudinal data on the clinical efficacy of drugs for rheumatoid arthritis (RA) are
available in the literature. This information can be used to optimize the clinical development …

Biologics including tumor necrosis factor α (TNF-α), interleukin-6 receptor (IL-6R), T and B
cell inhibitors are very effective therapeutic agents for the treatment of arthritides. These …

This literature review examines available evidence on the current and past costs associated
with rheumatoid arthritis (RA) in Italy, together with the future health-economic prospects for …

Defective clearance of apoptotic cells due to impaired efferocytosis sustains error in self-
tolerance that exacerbates rheumatoid arthritis (RA). However, the molecular determinant …

Conventional DMARDs such as MTX are the mainstay of treatment for patients with RA.
However, failure to achieve adequate disease control in many patients, even with …

An important goal for personalized treatment is predicting response to a particular
therapeutic. A drawback of biological treatment is immunogenicity and the development of …